摘要:
A method and apparatus are described including determining if a successful unicast transmission has occurred, adjusting a contention window to a minimum value and adjusting a time slot back-off counter to one-half of the value of the contention window plus one responsive to the determination and adjusting the contention window using one of a plurality of adjustment schemes and selecting said time slot back-off counter from an interval between zero and the contention window.
摘要:
Novel compounds are provided which are 11-beta-hydroxysteroid dehydrogenase type I inhibitors. 11-beta-hydroxysteroid dehydrogenase type I inhibitors are useful in treating, preventing, or slowing the progression of diseases requiring 11-beta-hydroxysteroid dehydrogenase type I inhibitor therapy. These novel compounds have the structure: or stereoisomers or prodrugs or pharmaceutically acceptable salts thereof wherein W, L, R3, R3a, R3b and R4 are defined herein.
摘要:
Novel heterocyclic aromatic compounds are provided that are useful in stimulating endogenous production or release of growth hormone, said compounds having the general structure of formula I wherein R1, R1a, R6, Xa, Xb and Y are as described herein. The compounds provided herein are useful in treating obesity, osteoporosis (improving bone density) and in improving muscle mass and muscle strength.
摘要:
The invention relates to a retinoid derivative and pharmaceutical composition and use thereof. The compound of the invention is capable of preventing or treating hematological tumors, such as acute leukemia, chronic leukemia, multiple myeloma and lymphoma, solid tumors, such as liver cancer, rectal cancer, mammary cancer and esophagus cancer, and skin disorders, such as psoriasis and acne.
摘要:
A functional model of a business process which is annotated with security requirements is provided. Platform-specific executable code and at least one configuration file for a given security enforcement component to enforce the security requirements of the model are then generated automatically.
摘要:
Novel compounds are provided which are 11-beta-hydroxysteroid dehydrogenase type I inhibitors. 11-beta-hydroxysteroid dehydrogenase type I inhibitors are useful in treating, preventing, or slowing the progression of diseases requiring 11-beta-hydroxysteroid dehydrogenase type I inhibitor therapy. These novel compounds of formula I: or stereoisomers or pharmaceutically acceptable salts thereof, wherein G, Q, X, Y, R3, R3a, and R3b are defined herein.
摘要:
A mobile station that is initially attached to a first type of wireless access network is involved in a packet-switched emergency call. Upon detection of transitioning of the mobile station, a message is sent indicating transitioning of the mobile station from the first type wireless access network to the second type wireless access network to cause the packet-switched emergency call to be performed over the second type wireless access network.
摘要:
In an embodiment, an apparatus includes a memory controller configured to control a plurality of daisy chained memory components connected over a daisy chained bus. The daisy chained bus includes a direct connection from the transmit interface of the memory controller to a receive interface of an initial memory component, and a daisy chain connection from a transmit interface of the initial memory component to a receive interface of a next memory component. A bus extends from a transmit interface of a last memory component directly to a receive interface of the memory controller.
摘要:
Novel heterocyclic aromatic compounds are provided that are useful in stimulating endogenous production or release of growth hormone, said compounds having the general structure of formula I wherein R1, R1′, R2, R3, R4, Xa, Y, Z and n are as described herein. The compounds provided herein are useful in treating obesity, osteoporosis (improving bone density) and in improving muscle mass and muscle strength.